首页> 外国专利> Administration of disodium chromoglycate or its biologues - by use of a primary dose which does not give inhibition of the allergy followed by a second anti-allergic dose

Administration of disodium chromoglycate or its biologues - by use of a primary dose which does not give inhibition of the allergy followed by a second anti-allergic dose

机译:给予铬糖酸二钠或其生物制剂-通过使用不会抑制变态反应的主要剂量,然后再使用第二个抗变应性剂量

摘要

Procedure for the administration of disodium chromoglycate (I) (disodium salt of 1,3-bis(2-carboxychromen-5-yloxy)-2-hydroxy-propane) and its biologues for the prophylactic treatment of reaginine or non-reaginine type allergies, by administration of a first dose of (I) or its biologues which does not assure effective inhibition of the allergic symptoms; followed by a second effective anti-allergic dose of (I) or its biologues in such a quantity that this second dose accures a stronger inhibition of the allergic symptoms than the first dose. Used for prophylactic treatment of allergies such as rhinitis, food allergies, asthma etc. The method of dosage gives high yields of inhibition of allergies with a total dose less than that used previously. The patient is less likely to develop resistance to (I) or suffer from side-effects.
机译:色甘酸二钠(I)(1,3-双(2-羧甲基-5-基氧基)-2-羟基丙烷的二钠盐)的给药程序及其生物制剂,用于预防性治疗菜籽素或非菜籽素类过敏通过给予不能确保有效抑制过敏症状的第一剂量的(I)或其生物制剂;其次是(I)的第二有效抗过敏剂量或其生物类似物,其用量应使该第二剂量对过敏症状的抑制作用强于第一剂量。用于过敏性疾病的预防性治疗,例如鼻炎,食物过敏,哮喘等。给药方法可产生高抑制率,总剂量比以前减少。患者不太可能对(I)产生抗药性或出现副作用。

著录项

  • 公开/公告号FR2274285B1

    专利类型

  • 公开/公告日1978-11-10

    原文格式PDF

  • 申请/专利权人 UPJOHN CY;

    申请/专利号FR19750018590

  • 发明设计人

    申请日1975-06-13

  • 分类号A61K31/00;

  • 国家 FR

  • 入库时间 2022-08-22 21:49:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号